Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hyperglycemia 2Lymphoma 1Insulin Resistance 1Hyperphagia 1Diabetes Mellitus, Type 2 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × Insulin Glargine × Clear all
NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
15 enrolled
Lymphoid

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed
61 enrolled

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡